Connecting you to content on EBSCOhost

Works by Toribio-Castelló, Sofía

Results: 4

1

Cost-Effectiveness of Elranatamab Versus Current Therapies for the Management of Patients with Triple-Class Exposed, Relapsed and Refractory Multiple Myeloma, Including Other Bispecific and Physician's Choice of Treatment in Spain.

Published in:

Oncology & Therapy, 2025, v. 13, n. 2, p. 381, doi. 10.1007/s40487-025-00333-7

By:

Encinas, Cristina;
Lozano, Virginia;
Hlavacek, Patrick;
Llinares, Julia;
Toribio-Castelló, Sofía;
Carcedo, David;
Asís-Montalt, Jordi;
Martínez-López, Joaquín

Publication type:

Article

2

Inhibitor of apoptosis proteins, NAIP, cIAP1 and cIAP2 expression during macrophage differentiation and M1/M2 polarization.

Published in:

PLoS ONE, 2018, v. 13, n. 3, p. 1, doi. 10.1371/journal.pone.0193643

By:

Morón-Calvente, Virginia;
Romero-Pinedo, Salvador;
Toribio-Castelló, Sofía;
Plaza-Díaz, Julio;
Abadía-Molina, Ana C.;
Rojas-Barros, Domingo I.;
Beug, Shawn T.;
LaCasse, Eric C.;
MacKenzie, Alex;
Korneluk, Robert;
Abadía-Molina, Francisco

Publication type:

Article

3

NAIP expression increases in a rat model of liver mass restoration.

Published in:

Journal of Molecular Histology, 2021, v. 52, n. 1, p. 113, doi. 10.1007/s10735-020-09928-y

By:

Plaza-Díaz, Julio;
Álvarez-Mercado, Ana I.;
Robles-Sánchez, Cándido;
Navarro-Oliveros, Miguel;
Morón-Calvente, Virginia;
Toribio-Castelló, Sofía;
Sáez-Lara, María José;
MacKenzie, Alex;
Fontana, Luis;
Abadía-Molina, Francisco

Publication type:

Article

4

Mutational Profile Enables the Identification of a High-Risk Subgroup in Myelodysplastic Syndromes with Isolated Trisomy 8.

Published in:

Cancers, 2023, v. 15, n. 15, p. 3822, doi. 10.3390/cancers15153822

By:

Toribio-Castelló, Sofía;
Castaño, Sandra;
Villaverde-Ramiro, Ángela;
Such, Esperanza;
Arnán, Montserrat;
Solé, Francesc;
Díaz-Beyá, Marina;
Díez-Campelo, María;
del Rey, Mónica;
González, Teresa;
Hernández-Rivas, Jesús María

Publication type:

Article